German multicenter study group for adult ALL (GMALL): Recruitment in comparison to ALL incidence and its impact on study results

Annals of Hematology

Volumn 82, Issue 2, 2003, Pages 83-87

  Dugas, M ^a   Messerer, D ^a   Hasford, J ^a   Haferlach, T ^b   Heinze, B ^c   Ludwig, W ^d   Rieder, H ^e   Schoch, R ^f   Schwartz, S ^g   Thiel, E ^g  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY OF ULM   (Germany)

^d HUMBOLDT UNIVERSITY   (Germany)

^e PHILIPPS UNIVERSITY MARBURG   (Germany)

^f UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^g CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Adult acute lymphoblastic leukemia; External validity; GMALL; Record linkage

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CANCER INCIDENCE; CANCER PATIENT; CANCER REGISTRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EPIDEMIOLOGICAL DATA; FACTUAL DATABASE; FEMALE; GERMANY; HOSPITAL ADMISSION; HUMAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; MULTICENTER STUDY; PATIENT REFERRAL; PATIENT SELECTION; PRIORITY JOURNAL; RELIABILITY; SEX DIFFERENCE; VALIDATION PROCESS; ACUTE LYMPHOCYTIC LEUKEMIA; AGED; EPIDEMIOLOGY; INCIDENCE; INFORMATION PROCESSING; MIDDLE AGED; REGISTER; STANDARD;

ADOLESCENT; ADULT; AGED; BIAS (EPIDEMIOLOGY); CLINICAL TRIALS; DATA COLLECTION; EPIDEMIOLOGIC RESEARCH DESIGN; FEMALE; GERMANY; HUMANS; INCIDENCE; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; MIDDLE AGED; PATIENT SELECTION; REGISTRIES;

EID: 0037676191     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-002-0585-x     Document Type: Article

References (22)

1. Hölzel D, Altwein J (1991) Tumors of the urogenital tract: clinico-epidemiologic fact Urologe A 30:134-138
2. Baltussen R, Leidl R, Amen A (1999) Real world designs in economic evaluation. Bridging the gap between clinical research and policy-making. Pharmacoeconomics 16:449-458
3. OTA (Office of Technology Assessment) (1983) The impact of randomized clinical trials on health policy and medical practice. U.S. Congress OTA-BP-H-22, Washington, D.C. p 95
4. Hasford J, Köpcke W (1984) Impact of clinical trials on medical practice: problems and consequences for research designs. In: v. Eimeren, Engelbrecht, Flagle (eds) Proceedings 3rd International Conference on System Science in Health Care. Springer, Berlin Heidelberg New York, pp 1128-1131
5. Moher D, Schulz KF, Altman DG, Lepage L (2001) The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 357:1191-1194
6. Britton A, McKee M, Black N McPherson K, Sanderson C Bain C (1999) Threats to applicability of randomised trials: exclusions and selective participation. J Health Serv Res Policy 4:112-121
7. Gökbuget N, Hoelzer D, Arnold R, Böhme A, Bartram CR, Freund M, et al. (2000) Treatment of Adult ALL according to protocols of the German Multicentre Study Group For Adult ALL (GMALL). Hematol Oncol Clin North Am 14:1307-1326
8. Durrant IJ, Richards SM, Prentice HG Goldstone AH (2000) The Medical Research Council trials in adult ALL. Hematol Oncol Clin North Am 14:1327-1352
9. Larson RA (2000) Recent trials in ALL by the Cancer and Leukaemia Group B. Hematol Oncol Clin North Am 14:1367-1380
10. Thiebaut A, Vernant JP, Degos L, Huguet FR, Reiffers J, Sebban C, et al. (2000) ALL Study testing chemotherapy and autologous and allogeneic transplantation: a follow-up report of the French protocol LALA 87. Hematol Oncol Clin North Am 14:1353-1366
11. Statistisches Bundesamt Deutschland [resource on World Wide Web] http://www.statistik-bund.de/basis/d/bevoe/bevoe-tab4.htm. Accessed 11 June 2001
12. Meinert R, Schuz J, Kaletsch U, Kaatsch P, Michaelis J (2000) Leukemia and non-Hodgkin's lymphoma in childhood and exposure to pesticides: results of a register-based case-control study in Germany. Am J Epidemiol 151:639-650
13. Wall L PERL [resource on World Wide Web] http://www.perl.com. Accessed 11 June 2001
14. McNally RJ, Rowland D, Roman E, Cartwright RA (1997) Age and sex distributions of hematological malignancies in the U.K. Hematol Oncol 15:173-189
15. Surveillance, Epidemiology, and End Results (SEER) Program Public Use Data (1973-1999), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2002, based on the November 2001 submission
16. Visser O, Coebergh JWW, Dijck JAAM van, Siesling S (eds) (2002) Incidence of cancer in the Netherlands 1998. Vereniging van Integrale Kankercentra, Utrecht
17. Harms DO, Janka-Schaub GE (2000) Co-operative study group for childhood acute lymphoblastic leukaemia (COALL): long-term follow-up of trials 82, 85, 89 and 92. Leukaemia 14:2234-2239
18. Schrappe M, Reiter A, Zimmermann M, Harbott J, Ludwig WD, Henze G, et al. (2000) Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Munster. Leukaemia 14:2205-2222
19. Davis CE (1994) Generalizing from clinical trials. Control Clin Trials 15:11-14
20. Chessells JM, Hall E, Prentice HG, et al. (1998) The impact of age on outcome in lymphoblastic leukaemia; MRC UKALL X and XA compared; a report from the MRC Paediatric and Adult Working Parties. Leukaemia 12:463-473
21. Secker-Walker LM, Prentice HG, Durrant J, Richards S, Hall E, Harrison G (1997) Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukaemia on MRC trial UKALL XA. Br J Haematol 96:601-610
22. Kendrick SW, Douglas MM, Gardner D, Hucker D (1999) Best-link matching of Scottish health data sets. IMIA Year-book. Schattauer, Stuttgart, pp 405-409